| Literature DB >> 31080834 |
Ewelina Malanowska1, Andrzej Starczewski1, Włodzimierz Bielewicz1, Matteo Balzarro2.
Abstract
BACKGROUND: Pelvic organ prolapses (POP) and overactive bladder (OAB) may coexist and both negatively impact quality of life in women. The correlation between POP and OAB remains unclear, but these patients may have the OAB resolution after the surgical treatment of POP. Aim of our study was to assess the anatomical results and the effect on OAB symptoms in women who underwent laparoscopic lateral suspension for POP.Entities:
Mesh:
Year: 2019 PMID: 31080834 PMCID: PMC6475562 DOI: 10.1155/2019/9051963
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Patients' characteristics.
| Demographics |
| |
|---|---|---|
| Age (years), mean (±SD) | 59.4 | (±9.3) |
| Menopausal status, n (%) | 60.0 | (93.7) |
| Systemic HRT at the time of surgery, n (%) | 10.0 | (15.6) |
| Body mass index, mean (±SD) | 26.8 | (±3.5) |
| Number of vaginal deliveries, mean (±SD) | 2.17 | (±1.1) |
| Birth weight of largest baby (g), mean (±SD) | 3.74 | (±421) |
| Age at the menopause (years), (±SD) | 49.9 | (±4.2) |
| Only uterine prolapse (%) | 14 | (21.9) |
| Uterine and anterior vaginal wall prolapse (%) | 50 | (78.1) |
HRT: hormone replacement therapy; SD:standard deviation.
Recurrences and reoperation rates.
| | % | |
|---|---|---|
| Total recurrences | 8 | 12.5 |
| Anterior vaginal wall recurrences | 2 | 3.1 |
| Apical recurrences | 3 | 4.7 |
| Enterocele recurrence | 1 | 1.6 |
| Posterior vaginal wall recurrences | 2 | 3,1 |
| Need for reoperation | 7 | 10.9 |
Objective assessment: preoperative and the follow-up.
| POP-Q parameters | Preoperative | Follow-up at 12 months |
|
|---|---|---|---|
|
|
| ||
| Aa | 0.80 (±0.95) | -1.69 (±0,89) | <0,001 |
| Ba | 1.67 (±1,13) | -1.63 (±1,11) | <0,001 |
| C | -0.06(1.63) | -5.55(±2,53) | <0,001 |
| GH | 4.00 (±0.59) | 2.77 (±0.75) | <0.001 |
| PB | 2.33 (±0.84) | 2.66 (±0.62) | <0.006 |
| TVL | 10 (±0) | 10 (±0) | - |
| Ap | -0.44 (±1.08) | -1.54(±1,04) | <0,001 |
| Bp | -0.47 (±1,01) | -2.19 (±2,29) | <0,001 |
POP-Q, Pelvic Organ Prolapse Quantification System.
Symptoms before surgery, and at the 12-month follow-up.
| Preoperative | Follow-up | Valuable positive change, | Valuable negative change, |
| |
|---|---|---|---|---|---|
| Bulging | 62/64 (96.9) | 10/64 (15.6) | 52/62 (83.9) | 0/2 (0.0) | <0,001 |
| UUI | 26/64 (40.6) | 10/64 (15.6) | 18/26 (69.2) | 2/38 (5.3) | <0,001 |
| SUI | 14/64 (21.9) | 7/64 (10.9) | 9/14 (64.3) | 2/50 (4.0) | <0,042 |
| Urinary frequency | 39/64 (60.9) | 13/64 (20.3) | 27/39 (69.2) | 1/25 (4.0) | <0,001 |
| Nocturia (≥ 1) | 28/64 (43.7) | 1/64 (1.6) | 27/28 (96.4) | - | <0,001 |
| Overactive Bladder | 25/64 (39.1) | 7/64 (10.9) | 19/25 (76.0) | 1/39 (2.6) | <0,001 |
| Constipation | 39/64 (60.9) | 22/64 (34.4) | 18/39 (46.1) | 1/25 (4.0) | <0,001 |
| Sexual activity | 37/64 (57.8) | 38/64 (59.4) | 3/27 (11.1) | 2/37 (5.4) | <0,658 |
UUI, urgency urinary incontinence; SUI, stress urinary incontinence, ∗ > 8 times/day.
Overactive bladder symptoms, and stress urinary incontinence at the 12-month follow-up.
|
| % | |
|---|---|---|
| Overactive bladder symptoms | ||
| Resolution | 19/25 | 76.0 |
| Persistence | 6/25 | 24.0 |
| De novo | 1/39 | 2.6 |
| Stress urinary incontinence | ||
| Resolution | 9/14 | 64.3 |
| Persistence | 5/14 | 35.7 |
| De novo | 2/50 | 4.0 |
Figure 1Subdivision of the cohort in three groups according to POP stage and correlation between stages and overactive bladder symptoms before surgery and at the 1-year follow-up. AVW, anterior vaginal wall; C, cervix; II, II°stage POP-Q; III, III°stage POP-Q.
Subjective changes measured by validated questionnaires before and after the surgical treatment.
| Questionnaires | Preoperative | Postoperative |
| ||
|---|---|---|---|---|---|
|
|
|
|
| ||
| PFDI20 | 99.2 | ± 33.4 | 16.5 | ±21.6 | <0,001 |
| POPDI6 | 51.0 | ± 18.3 | 4.2 | ±10.7 | <0,001 |
| CRADI8 | 9.1 | ± 9.8 | 4.8 | ±7.6 | <0,001 |
| UDI6 | 39.1 | ± 22.3 | 7.4 | ±13.3 | <0,001 |
PFDI20, Pelvic Floor Distress Inventory; POPDI6, Pelvic Organ Prolapse Distress Inventory; CRADI6, Colorectal-anal distress inventory; UDI6, Urinary Distress Inventory.
Figure 2Representation of change before and after surgical treatment at the questionnaires. PFDI20, Pelvic Floor Distress Inventory, POPDI6, Pelvic Organ Prolapse Distress Inventory, CRADI6, Colorectal-anal distress inventory, UDI6, Urinary Distress Inventory.